| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |